Skip to main content
David Miyamoto, MD, Radiation Oncology, Boston, MA, Emerson Hospital

DavidT.MiyamotoMDPhD

Radiation Oncology Boston, MA

Assistant Professor of Radiation Oncology, Massachusetts General Hospital

Dr. Miyamoto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Miyamoto's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2024
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer  
    David T Miyamoto, Aditya Bardia, Lecia V Sequist, Laura M Spring, Daniel A Haber, Mark Kalinich, Clinical Cancer Research

Press Mentions

  • New Discovery by Massachusetts General Hospital May Help Medical Laboratories Preserve Blood for DNA Analysis, Thus Allowing Isolation of CTCs up to 72 Hours After Collection
    New Discovery by Massachusetts General Hospital May Help Medical Laboratories Preserve Blood for DNA Analysis, Thus Allowing Isolation of CTCs up to 72 Hours After CollectionJune 27th, 2018
  • Henning Willers, MD and David Miyamoto, MD, PhD Receive $150,000 Grant from Aid for Cancer Research
    Henning Willers, MD and David Miyamoto, MD, PhD Receive $150,000 Grant from Aid for Cancer ResearchMay 21st, 2018
  • New Way to Preserve Tumor Biomarkers in Blood Could Lead to Better Treatment Decisions
    New Way to Preserve Tumor Biomarkers in Blood Could Lead to Better Treatment DecisionsJanuary 9th, 2018
  • Join now to see all

Hospital Affiliations